Keros Therapeutics, Inc. (KROS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 367K | 385K | 14.26M | 18.17M | 211.25M | 3.04M | 388K | 37K | 83K | 143K | 8K | 0 | 0 | 0 | 0 | 0 | 0 | 20M | 0 | 100K |
| Revenue Growth % | -99.83% | -87.34% | 3575.77% | 49002.7% | 254413.25% | 2027.27% | 4750% | - | - | - | - | - | - | -100% | - | -100% | - | - | - | - |
| Cost of Goods Sold | 403K | 0 | 395K | 370K | 0 | 332K | 314K | 0 | 0 | 0 | 551K | 0 | 0 | 0 | 0 | 0 | 0 | 302K | 0 | 9.98M |
| COGS % of Revenue | 109.81% | - | 2.77% | 2.04% | - | 10.91% | 80.93% | - | - | - | 6887.5% | - | - | - | - | - | - | 1.51% | - | 9983% |
| Gross Profit | -36K | 385K | 13.87M | 17.8M | 211.25M | 2.71M | 74K | 37K | 83K | 143K | -543K | 0 | 0 | 0 | 0 | 0 | 0 | 19.7M | 0 | -9.88M |
| Gross Margin % | -9.81% | 100% | 97.23% | 97.96% | 100% | 89.09% | 19.07% | 100% | 100% | 100% | -6787.5% | - | - | - | - | - | - | 98.49% | - | -9883% |
| Gross Profit Growth % | -100.02% | -85.79% | 18639.19% | 48002.7% | 254413.25% | 1795.1% | 113.63% | - | - | - | - | - | - | -100% | - | 100% | - | - | - | - |
| Operating Expenses | 25.84M | 29.66M | 29.25M | 57.62M | 59.21M | 55.96M | 58.73M | 50.48M | 48.57M | 46.6M | 42.74M | 41.34M | 38.87M | 31.96M | 27.98M | 30.73M | 24.13M | 24.56M | 20.2M | 5.66M |
| OpEx % of Revenue | 7041.14% | 7702.6% | 205.1% | 317.12% | 28.03% | 1839.71% | 15136.86% | 136421.62% | 58513.25% | 32586.01% | 534212.5% | - | - | - | - | - | - | 122.82% | - | 5658% |
| Selling, General & Admin | 10.15M | 11.74M | 10.13M | 14.48M | 10.5M | 10.66M | 9.82M | 9.96M | 10.31M | 9.11M | 8.6M | 8.8M | 7.78M | 7.09M | 6.94M | 7.45M | 6.05M | 5.73M | 5.37M | 5.66M |
| SG&A % of Revenue | 2764.85% | 3050.13% | 71.01% | 79.71% | 4.97% | 350.59% | 2530.93% | 26921.62% | 12419.28% | 6367.13% | 107462.5% | - | - | - | - | - | - | 28.66% | - | 5658% |
| Research & Development | 16.1M | 17.91M | 19.52M | 43.5M | 48.71M | 45.63M | 49.23M | 40.52M | 38.26M | 37.49M | 34.14M | 32.53M | 31.09M | 24.87M | 21.04M | 23.28M | 18.08M | 18.83M | 14.83M | 9.98M |
| R&D % of Revenue | 4386.1% | 4652.47% | 136.86% | 239.45% | 23.06% | 1500.03% | 12686.86% | 109500% | 46093.98% | 26218.88% | 426750% | - | - | - | - | - | - | 94.17% | - | 9983% |
| Other Operating Expenses | -403K | 0 | -395K | -370K | 0 | -332K | -314K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | -25.88M | -29.27M | -15.38M | -39.82M | 152.04M | -53.25M | -58.66M | -50.44M | -48.48M | -46.45M | -43.28M | -41.34M | -38.87M | -31.96M | -27.98M | -30.73M | -24.13M | -4.87M | -20.2M | -15.54M |
| Operating Margin % | -7050.95% | -7602.6% | -107.87% | -219.16% | 71.97% | -1750.62% | -15117.78% | -136321.62% | -58413.25% | -32486.01% | -541000% | - | - | - | - | - | - | -24.33% | - | -15541% |
| Operating Income Growth % | -117.02% | 45.04% | 73.77% | 21.06% | 413.59% | -14.64% | -35.53% | -22.02% | -24.73% | -45.35% | -54.7% | -34.53% | -61.11% | -556.8% | -38.52% | -97.72% | -53% | 63.39% | -69.04% | -42.4% |
| EBITDA | -25.47M | -28.87M | -14.99M | -39.45M | 152.38M | -52.92M | -58.34M | -50.13M | -48.21M | -46.21M | -42.73M | -41.15M | -38.7M | -31.83M | -27.85M | -30.42M | -24.01M | -4.56M | -20.09M | -15.35M |
| EBITDA Margin % | -6941.14% | -7498.7% | -105.1% | -217.12% | 72.14% | -1739.71% | -15036.86% | -135494.59% | -58079.52% | -32313.29% | -534112.5% | - | - | - | - | - | - | -22.82% | - | -15347% |
| EBITDA Growth % | -116.72% | 45.45% | 74.31% | 21.32% | 416.11% | -14.53% | -36.54% | -21.84% | -24.56% | -45.16% | -53.43% | -35.26% | -61.17% | -597.48% | -38.6% | -98.21% | -53.06% | 65.47% | -69.2% | -41.5% |
| D&A (Non-Cash Add-back) | 403K | 400K | 395K | 370K | 344K | 332K | 314K | 306K | 277K | 247K | 551K | 191K | 167K | 127K | 126K | 308K | 113K | 302K | 103K | 194K |
| EBIT | -25.88M | -29.27M | -8.7M | -32.92M | 152.04M | -29.47M | -58.66M | -50.44M | -48.48M | -40.24M | -39.44M | -41.34M | -38.87M | -29.72M | -23.51M | -27.27M | -24.18M | -4.94M | -20.33M | -15.62M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | -1K | -1K | -1K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K | 1K |
| Other Income/Expense | 2.17M | 4.29M | 6.68M | 6.9M | 6.45M | 7.53M | 5.7M | 5.18M | 5.37M | 6.21M | 3.84M | 3.83M | 3.06M | 2.24M | 4.47M | 3.46M | -60K | -75K | -138K | -81K |
| Pretax Income | -23.71M | -24.98M | -8.7M | -32.92M | 158.49M | -45.73M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -35.8M | -29.72M | -23.51M | -27.27M | -24.19M | -4.94M | -20.34M | -15.62M |
| Pretax Margin % | -6459.95% | -6487.01% | -61.03% | -181.19% | 75.03% | -1503.16% | -13648.45% | -122316.22% | -51944.58% | -28141.96% | -493000% | - | - | - | - | - | - | -24.7% | - | -15622% |
| Income Tax | 0 | -1.51M | -1.42M | -2.22M | 10.04M | 300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -38K | 0 |
| Effective Tax Rate % | 0% | 6.06% | 16.36% | 6.75% | 6.34% | -0.66% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -40.44% | 0.19% | 0% |
| Net Income | -23.71M | -23.46M | -7.28M | -30.7M | 148.45M | -46.03M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -35.8M | -29.72M | -23.51M | -27.27M | -24.19M | -6.94M | -20.3M | -15.62M |
| Net Margin % | -6459.95% | -6093.77% | -51.04% | -168.96% | 70.27% | -1513.02% | -13648.45% | -122316.22% | -51944.58% | -28141.96% | -493000% | - | - | - | - | - | - | -34.7% | - | -15622% |
| Net Income Growth % | -115.97% | 49.03% | 86.25% | 32.17% | 444.32% | -14.37% | -34.27% | -20.67% | -20.42% | -35.42% | -67.77% | -37.55% | -48.04% | -328.21% | -15.82% | -74.54% | -52.26% | 34.99% | -68.64% | -45.23% |
| Net Income (Continuing) | -23.71M | -23.46M | -7.28M | -30.7M | 148.45M | -46.03M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -35.8M | -29.72M | -23.51M | -27.27M | -24.19M | -6.94M | -20.3M | -15.62M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.63 | -0.38 | -0.18 | -0.76 | 3.62 | -1.14 | -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.30 | -0.87 | -0.67 |
| EPS Growth % | -117.4% | 66.67% | 87.76% | 39.2% | 347.95% | 14.93% | -10.53% | 1.57% | -26.96% | -22.94% | -77.33% | -28.28% | -13.86% | -263.33% | 13.79% | -47.76% | -48.53% | 38.78% | -45.84% | -7.71% |
| EPS (Basic) | -0.64 | -0.86 | -0.18 | -0.76 | 3.66 | -1.14 | -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.30 | -0.87 | -0.67 |
| Diluted Shares Outstanding | 37.86M | 37.86M | 40.62M | 40.61M | 41.02M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M |
| Basic Shares Outstanding | 37.22M | 37.22M | 40.62M | 40.61M | 40.56M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |